Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Piper Sandler Analyst Maintains Overweight Rating on EPAM Systems with 369 Price Target

Elaine Mendonca by Elaine Mendonca
March 4, 2024
in Breaking News
0
The Rise of Enterprise Business Intelligence Platforms: Transforming Operations in the Healthcare Sector
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

Analyst Arvind Ramnani of Piper Sandler has once again expressed confidence in EPAM Systems (NYSE: EPAM), giving it an Overweight rating and sticking to a price target of $369. This latest show of support comes after Piper Sandler previously upgraded their view on EPAM Systems from Neutral to Overweight on November 2, 2023, raised the price target from $265 to $339 on January 4, 2024, and then bumped it up to $369 on February 15, 2024. These consistent endorsements and price target adjustments signal Piper Sandler’s optimistic stance on EPAM Systems.

Date: March 4, 2024

EPAM Systems, Inc. Stock Soars on Strong Performance – March 4, 2024

On March 4, 2024, EPAM Systems, Inc. (EPAM) showed strong performance in the stock market as it traded near the top of its 52-week range and above its 200-day simple moving average. According to data from CNN Money, EPAM shares saw a price increase of $2.43 on March 4, 2024, closing at $306.83. This represents a 0.80% rise in the stock price from the previous trading day. EPAM is a leading global provider of digital platform engineering and software development services. Investors are likely optimistic about EPAM’s future prospects, given its strong performance in the stock market. Overall, EPAM’s stock performance on March 4, 2024, reflects the company’s strong fundamentals and positive outlook. EPAM’s stock is definitely one to watch for investors looking for opportunities in the technology sector.

EPAM Systems, Inc. Reports Flat Financial Performance for 2023 – SEO Title

On March 4, 2024, EPAM Systems, Inc. (EPAM) reported its financial performance for the past year and the fourth quarter. According to data from CNN Money, the company’s total revenue for the past year was $4.69 billion, which remained flat compared to the previous year. Similarly, the total revenue for the fourth quarter was $1.16 billion, holding steady since the previous quarter.

EPAM’s net income for the past year was reported at $417.08 million, which also remained flat compared to the previous year. The net income for the fourth quarter was $97.55 million, holding steady since the previous quarter.

Earnings per share (EPS) for the past year was reported at $7.06, which remained flat compared to the previous year. The EPS for the fourth quarter was $1.66, holding steady since the previous quarter.

Overall, EPAM’s financial performance on March 4, 2024, showed that the company’s total revenue, net income, and earnings per share remained flat since the previous year and the previous quarter. This suggests that the company’s financial stability and performance have been consistent over the past year.

Tags: EPAM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
CRWD stock news

Analyst Bullish on Ciena with Increased Price Target

Finance_Commercial

Wells Fargo Upgrades Price Target for CrowdStrike Holdings Expresses Bullish Stance

Tech-banking-finance

Analyst Reaffirms Buy Rating for Geron with 4 Price Target

Recommended

Lockheed Martin Stock

Defense Giant Lockheed Martin Secures Billions in New Military Contracts

6 months ago
OKE stock news

Amalgamated Bank Increases Stake in CF Industries as Market Opinions Vary

3 years ago
IBM Stock

IBM’s AI Windfall Fails to Impress Stock Market

7 months ago
Blackstonecured Lending Fund Stock

Blackstone BDC Insider Purchase Defies Analyst Downgrades

4 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Figma Embraces Third-Party AI to Power Its Design Ecosystem

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

Humacyte Shares Hit Record Low Amid Capital Raise and Strategic Shifts

Evolent Health Bets on AI Leadership Amid Share Price Decline

MongoDB Strengthens Leadership Amid AI-Driven Growth Phase

Talphera Shares Slide as Funding Concerns Overshadow Clinical Progress

Trending

Gossamer Bio Stock
Analysis

Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026

by Kennethcix
March 25, 2026
0

The future of Gossamer Bio hinges on a critical regulatory discussion scheduled for June 2026. The biopharmaceutical...

SOXX ETF Stock

Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns

March 25, 2026
Fair Isaac Stock

Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

March 25, 2026
Figma Stock

Figma Embraces Third-Party AI to Power Its Design Ecosystem

March 25, 2026
BioNano Genomics Stock

BioNano Genomics Stock: A Tale of Operational Gains and Revenue Headwinds

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Gossamer Bio’s Pivotal FDA Meeting Looms in June 2026
  • Semiconductor Sector Faces Supply Chain Strain Amid Helium Shortage Concerns
  • Regulatory Scrutiny and Price Wars Threaten Fair Isaac’s Dominance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com